Tranexamic acid for percutaneous nephrolithotomy: an abridged Cochrane Review.

Brent ClevelandBrett NorlingHill WangVardhil GandhiCarrie L PriceMichael BorofskyVernon PaisPhilippe D Violette

Published in: BJU international (2023)

Based on a body of evidence of 10 RCTs, we found that systemic TXA in PCNL may reduce blood transfusions, major surgical complications, and hospital LOS, as well as improve SFR; however, it may increase AE. These findings should inform urologists and their patients in making informed decisions about the use of TXA in the setting of PCNL.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
prognostic factors
risk factors
minimally invasive
emergency department
radiofrequency ablation